AR009105A1 - Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica - Google Patents

Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica

Info

Publication number
AR009105A1
AR009105A1 ARP970104493A ARP970104493A AR009105A1 AR 009105 A1 AR009105 A1 AR 009105A1 AR P970104493 A ARP970104493 A AR P970104493A AR P970104493 A ARP970104493 A AR P970104493A AR 009105 A1 AR009105 A1 AR 009105A1
Authority
AR
Argentina
Prior art keywords
therapeutics
benzotiazol
ethanamine
piperidine
derivatives
Prior art date
Application number
ARP970104493A
Other languages
English (en)
Original Assignee
Wicke K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wicke K filed Critical Wicke K
Publication of AR009105A1 publication Critical patent/AR009105A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuestos que responden a la formula general (I) en la cual n representa el numero 0, 1, 2 o 3, R1, representa un átomo de hidrogeno o de halogeno o ungrupo metilo o metoxi, R2 representa un átomo de hidrogeno o un grupo metilo y R3 representa unátomo de hidrogeno o uno o dos átomos de halogeno. Aplicacionen terapéutica.
ARP970104493A 1996-10-01 1997-09-30 Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica AR009105A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9611925A FR2753970B1 (fr) 1996-10-01 1996-10-01 Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR009105A1 true AR009105A1 (es) 2000-03-08

Family

ID=9496217

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104493A AR009105A1 (es) 1996-10-01 1997-09-30 Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica

Country Status (23)

Country Link
EP (1) EP0929550A1 (es)
JP (1) JP2001501217A (es)
KR (1) KR20000048767A (es)
CN (1) CN1230959A (es)
AR (1) AR009105A1 (es)
AU (1) AU722147B2 (es)
BG (1) BG103271A (es)
BR (1) BR9711842A (es)
CA (1) CA2266510A1 (es)
CO (1) CO4650030A1 (es)
CZ (1) CZ112699A3 (es)
EE (1) EE9900135A (es)
FR (1) FR2753970B1 (es)
HU (1) HUP9904091A3 (es)
IL (1) IL128902A (es)
NO (1) NO991581L (es)
NZ (1) NZ334553A (es)
PL (1) PL332648A1 (es)
SK (1) SK42299A3 (es)
TR (1) TR199900634T2 (es)
TW (1) TW438800B (es)
WO (1) WO1998014444A1 (es)
ZA (1) ZA978772B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
AU8181701A (en) 2000-06-21 2002-01-02 Hoffmann La Roche Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
AU2004283842A1 (en) * 2003-10-24 2005-05-06 F. Hoffmann-La Roche Ag CCR3 receptor antagonists
NZ550763A (en) 2004-05-24 2010-07-30 Hoffmann La Roche 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
WO2006048172A1 (en) 2004-11-05 2006-05-11 F. Hoffmann-La Roche Ag Process for preparation of isonicotinic acid derivatives
KR100968989B1 (ko) 2005-03-23 2010-07-09 에프. 호프만-라 로슈 아게 mGluR2 길항제로서 아세틸렌일-피라졸로-피리미딘 유도체
ES2340321T3 (es) 2005-09-27 2010-06-01 F.Hoffmann-La Roche Ag Oxadiazolilpirazolo-pirimidinas, como antagonistas de mglur2.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법

Also Published As

Publication number Publication date
CN1230959A (zh) 1999-10-06
AU4463897A (en) 1998-04-24
NZ334553A (en) 2000-11-24
AU722147B2 (en) 2000-07-20
FR2753970B1 (fr) 1998-10-30
FR2753970A1 (fr) 1998-04-03
WO1998014444A1 (fr) 1998-04-09
IL128902A (en) 2001-07-24
JP2001501217A (ja) 2001-01-30
HUP9904091A3 (en) 2000-07-28
NO991581L (no) 1999-06-01
EP0929550A1 (fr) 1999-07-21
CO4650030A1 (es) 1998-09-03
KR20000048767A (ko) 2000-07-25
SK42299A3 (en) 1999-12-10
CZ112699A3 (cs) 1999-06-16
IL128902A0 (en) 2000-02-17
BR9711842A (pt) 1999-08-24
TW438800B (en) 2001-06-07
HUP9904091A2 (hu) 2000-05-28
CA2266510A1 (en) 1998-04-09
EE9900135A (et) 1999-12-15
BG103271A (en) 2000-05-31
NO991581D0 (no) 1999-03-30
ZA978772B (en) 1998-03-27
PL332648A1 (en) 1999-09-27
TR199900634T2 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
DK1200418T3 (da) Nematodicide trifluorbutener
RS49673B (sr) Inhibitori sintaze azot-monoksida
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
ES2195970T3 (es) L-ribavirina y usos de la misma.
DE69124224D1 (de) Wiederherstellung der Kante eines Schaufelblattes
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
FI921598A0 (fi) Transdermal komposition.
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
DE60121461D1 (de) Kondensierte pyridoindolderivate
CO4700298A1 (es) Derivados de 3-fenilisoquinoleina-1 (2h)-ona, su preparacion y su aplicacion en la terapeutica
DE69021872D1 (de) Modifizierte Lösungsmittelzusammensetzungen.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
ES2084015T3 (es) Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
FR2847899B1 (fr) Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
MX9204179A (es) Derivados de imidazo(2,1-b)benzotiazola-3-acetamida, su preparacion y su aplicacion en terapeutica.
DZ1576A1 (fr) Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
ES2194457T3 (es) Complejo de platino, su preparacion y aplicacion terapeutica.
YU31191A (sh) Novi derivati beta-fenilizoserina njegovo dobijanje i primena

Legal Events

Date Code Title Description
FA Abandonment or withdrawal